Following initiatives by the Head of Research, Professor Tjeerd van Staa, the research utility of GPRD was dramatically enhanced by linkage to other datasets on an individual patient level. External datasets included the Hospital Episode Statistics, death certificates, the national cancer registry and MINAP (cardiovascular disease) registry. Additionally the dataset became that of choice by the FDA and most major pharma companies.
